Acute myeloid leukemia (AML): What it is, how it’s treated and what’s on the horizon

Dr. Ryan Stubbins, fellow at the BC Cancer Genome Sciences Centre and the Leukemia/BMT Program of BC, will discuss what AML is, how it develops, how it is treated, and some of the most promising new treatments for the disease.

Virtual Event

Virtual Event


14:00 - 14:50
AML: What it is, how it’s treated and what’s on the horizon
14:50 - 15:00


Dr. Ryan Stubbins
Dr. Ryan Stubbins, MD, MSc, FRCPC
Hematologist, Leukemia/BMT Program of British Columbia, BC Cancer and Vancouver Coastal Health Clinical Assistant Professor (pending), Department of Medicine, University of British Columbia
Dr. Ryan Stubbins is an academic and clinical Hematologist in the Leukemia/BMT Program of BC at BC Cancer. His clinical and research interests focus on myeloid malignancies, including myelodysplastic syndromes and acute myeloid leukemia, with a specific focus on genomic features of these diseases. He previously completed his medical and research training at the University of Saskatchewan, University of Alberta, and the University of British Columbia, and spent time as a visiting scholar at the University of Chicago.​